A more recent study extended this notion demonstrating that psychiatric symptoms, cognitive impairment, and olfactory deficiency are more pronounced in PD patients carrying severe GBA1 mutations (Thaler et al., 2018a). This evidence concerns the gene GBA1 and Cognitive impairment.